Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin and liraglutide injections for obesity reduction
IRCT20240311061259N2Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2024
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of neuronox and liraglutide in obesity and Overweight, sponsored by Shahid Beheshti University of Medical Sciences. Started Nov 2024; status: completed.
02
Drugs
neuronoxliraglutide
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on IRCT20240311061259N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240311061259N2.